Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 5/20 | 0.42 |
| ▸ | PLA2G10 | O15496 | 3/20 | 0.41 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | AURKA | O14965 | 1/20 | 0.37 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CERT1 | Q9Y5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14902202 | 0.90 | MME (0.39) | MMEPLA2G10TAS1R3TAS1R1CNR1 | |
| SCHEMBL20438368 | 0.88 | PLA2G10 (0.44) | MMEPLA2G10ALDH1A1LMNA | |
| SCHEMBL10902934 | 0.87 | ALDH1A1 (0.49) | MMEPLA2G10TAS1R3TAS1R1CNR1 | |
| SCHEMBL10902941 | 0.87 | ALDH1A1 (0.49) | MMEPLA2G10TAS1R3TAS1R1CNR1 | |
| SCHEMBL4341862 | 0.84 | TAS1R3 (0.42) | MMETAS1R3TAS1R1CNR1ALDH1A1 | |
| SCHEMBL21609362 | 0.84 | PLA2G10 (0.51) | MMEPLA2G10TAS1R3TAS1R1HDAC6 | |
| SCHEMBL27105837 | 0.84 | PLA2G10 (0.47) | MMEPLA2G10TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL25291547 | 0.82 | ALDH1A1 (0.42) | MMEPLA2G10TAS1R3TAS1R1CNR1 | |
| SCHEMBL11073459 | 0.82 | ALDH1A1 (0.52) | MMETAS1R3TAS1R1CNR1ALDH1A1 | |
| SCHEMBL3306198 | 0.82 | ALDH1A1 (0.42) | MMEPLA2G10TAS1R3TAS1R1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612236-B2 | Method for producing optically active bisamidoalcohol compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-11-03 | — | — | US | disclosed |
| US-20070100163-A1 | Reacting an optically active aminoalcohol compound with a diester compound in the presence of a lithium compound wherein the lithium compound is selected from lithium hydroxide, a lithium alkoxide and a lithium halide; product can be efficiently and inexpensively produced | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-05-03 | — | — | US | disclosed |
| EP-1698616-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE BISAMIDO ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2006-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070100163-A1 | Reacting an optically active aminoalcohol compound with a diester compound in the presence of a lithium compound wherein the lithium compound is selected from lithium hydroxide, a lithium alkoxide and a lithium halide; product can be efficiently and inexpensively produced | CCNL2, ARL1, ACSL3 | MME 3690/4885PLA2G10 2533/4885TAS1R3 2130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.